[Federal Register Volume 69, Number 154 (Wednesday, August 11, 2004)]
[Notices]
[Pages 48874-48875]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-18331]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-04-04JW]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 498-1210 or send an e-mail to [email protected].
    CDC is requesting an emergency clearance for this data collection 
with a two week public comment period. CDC is requesting OMB approval 
of this

[[Page 48875]]

package 7 days after the end of the public comment period. While there 
is currently no SARS outbreak, expedited clearance is needed because 
the season when SARS outbreaks are most likely to occur is quickly 
approaching.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Seleda M. Perryman, 
CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS-E11, 
Atlanta, GA 30333. Written comments should be received within 14 days 
of this notice.

Proposed Project

    SARS Laboratory Safety Survey--New--National Center for Infectious 
Diseases (NCID), Centers for Disease Control and Prevention (CDC).
    During the past year, incidents of lab-acquired SARS-CoV infection 
have occurred at research institutions in China, Singapore, and Taiwan. 
As part of measures taken by CDC to prevent lab-acquired SARS 
infections in the United States, the Respiratory and Enteric Virus 
Branch (REVB) would like to collect information on current biosafety 
practices and use of live SARS-CoV from U.S. institutions that have 
obtained the virus, either from CDC or from other sources.
    Response data will be used to determine to what extent research 
involving live SARS-CoV and other biosafety level 3 pathogens is being 
conducted, the safety of the research environment, information about 
biosafety training, and the level of lab worker experience with BSL-3 
pathogens. Expedited collection of this information is necessary to 
ascertain the safety of environments where live SARS-CoV research may 
be taking place and to potentially address any deficiencies that may 
exist. There is no cost to the respondents.

--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                            No. of        Avg. burden/
                     Form                                    Respondent                    No. of         responses/      response (in     Total burden
                                                                                        respondents       respondent         hrs.)            hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Safety Survey for Laboratories Conducting      Laboratorians........................             120                1            10/60               20
 Research with live SARS-CoV and Other BSL-3
 Pathogens.
                                              ----------------------------------------
    Total....................................  .....................................  ...............  ...............  ...............              20
--------------------------------------------------------------------------------------------------------------------------------------------------------


    Dated: August 4, 2004.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 04-18331 Filed 8-10-04; 8:45 am]
BILLING CODE 4163-18-P